DOI: 10.1111/jdv.20030 ISSN: 0926-9959

Adaptive designs in dermatology clinical trials: Current status and future perspectives

D. Potvin, P. D'Angelo, S. Bennett, J. Jankicevic, R. Bissonnette
  • Infectious Diseases
  • Dermatology

Abstract

Current drug development strategies present many challenges that can impede drug approval by regulatory agencies. Alternative study models, such as adaptive trial designs, have recently sparked interest, as they provide a flexible and more efficient approach in conducting clinical trials. Adaptive trial designs offer several potential benefits over traditional randomized controlled trials, which include decrease in costs, reduced clinical development time and limiting exposure of patients to potentially ineffective treatments allowing completion of studies with fewer patients. This article explores the current use of adaptive trial designs in non‐oncologic skin diseases and highlights the most common types of adaptive designs used in the field. We also review the operational challenges and statistical considerations associated with such designs and propose clinical development strategies to successfully implement adaptive designs. The article also proposes instances where adaptive trial designs are particularly beneficial, and other situations where they may not be very useful.

More from our Archive